UnitedHealth Group Incorporated $UNH Shares Acquired by Capitolis Liquid Global Markets LLC

Capitolis Liquid Global Markets LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2,232.7% in the 4th quarter, HoldingsChannel reports. The firm owned 209,940 shares of the healthcare conglomerate’s stock after purchasing an additional 200,940 shares during the period. Capitolis Liquid Global Markets LLC’s holdings in UnitedHealth Group were worth $69,303,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in UNH. Casdin Capital LLC grew its holdings in UnitedHealth Group by 100.0% in the 4th quarter. Casdin Capital LLC now owns 50,000 shares of the healthcare conglomerate’s stock valued at $16,506,000 after buying an additional 25,000 shares during the period. Cinctive Capital Management LP grew its holdings in shares of UnitedHealth Group by 117.2% during the 4th quarter. Cinctive Capital Management LP now owns 12,359 shares of the healthcare conglomerate’s stock worth $4,080,000 after purchasing an additional 6,670 shares during the period. Argyle Capital Partners LLC lifted its position in UnitedHealth Group by 7.6% during the 4th quarter. Argyle Capital Partners LLC now owns 1,859 shares of the healthcare conglomerate’s stock worth $614,000 after acquiring an additional 131 shares in the last quarter. Bamco Inc. NY lifted its position in UnitedHealth Group by 39.5% during the 4th quarter. Bamco Inc. NY now owns 6,000 shares of the healthcare conglomerate’s stock worth $1,981,000 after acquiring an additional 1,700 shares in the last quarter. Finally, Banco Bilbao Vizcaya Argentaria S.A. raised its position in shares of UnitedHealth Group by 28.1% in the 4th quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 94,651 shares of the healthcare conglomerate’s stock valued at $31,301,000 after purchasing an additional 20,755 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 2.0%

NYSE:UNH opened at $399.33 on Thursday. The business has a fifty day moving average of $369.93 and a 200-day moving average of $328.55. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $415.98. The stock has a market cap of $362.65 billion, a price-to-earnings ratio of 30.16, a PEG ratio of 1.64 and a beta of 0.64. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.80 and a current ratio of 0.80.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share for the quarter, beating the consensus estimate of $6.76 by $0.47. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The business had revenue of $111.65 billion during the quarter, compared to analysts’ expectations of $109.84 billion. During the same quarter last year, the business posted $7.20 earnings per share. The company’s quarterly revenue was up 2.0% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Equities analysts predict that UnitedHealth Group Incorporated will post 18.32 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 23rd. Stockholders of record on Monday, June 15th will be issued a dividend of $2.32 per share. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.21. This represents a $9.28 annualized dividend and a dividend yield of 2.3%. The ex-dividend date of this dividend is Monday, June 15th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 70.09%.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the company. Royal Bank Of Canada upped their target price on UnitedHealth Group from $361.00 to $400.00 and gave the company an “outperform” rating in a research report on Wednesday, April 22nd. Bank of America raised UnitedHealth Group from a “neutral” rating to a “buy” rating and upped their price target for the company from $420.00 to $450.00 in a research report on Thursday, June 4th. Robert W. Baird upped their price objective on UnitedHealth Group from $278.00 to $287.00 and gave the stock an “underperform” rating in a research note on Wednesday, April 22nd. HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $300.00 price objective for the company in a research note on Tuesday, April 7th. Finally, Weiss Ratings upgraded UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, May 7th. One investment analyst has rated the stock with a Strong Buy rating, twenty have issued a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average target price of $409.75.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Leerink Partners raised its price target on UnitedHealth Group to $462 from $400 and reiterated an outperform rating, citing improved margin expectations at Optum Health and signaling confidence in the company’s recovery efforts. Leerink Raises UnitedHealth PT
• Positive Sentiment: Wall Street commentary has grown more constructive on UnitedHealth’s turnaround, with analysts pointing to better long-term profitability at its Optum Health unit as a reason the stock could recover further. UnitedHealth Stock Gets a Target Price Increase
• Neutral Sentiment: Separate coverage noted that hedge funds have continued to buy UnitedHealth, suggesting institutional interest remains solid, though this is not a direct catalyst by itself. Hedge Funds Bought UnitedHealth
• Neutral Sentiment: One investor-letter item said Sustainable Growth Advisers sold its stake in UNH, but the article provided limited detail on the reason, so the stock impact is unclear. SGA Sold UnitedHealth Stake
• Negative Sentiment: Despite the bullish analyst note, UNH also traded lower than the broader market in the latest session, reflecting that investors are still cautious about the pace and durability of the turnaround. UnitedHealth Fell More Than Broader Market

Insider Transactions at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 800 shares of the stock in a transaction dated Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total value of $284,000.00. Following the completion of the sale, the chief executive officer directly owned 17,805 shares of the company’s stock, valued at approximately $6,320,775. This represents a 4.30% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.28% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.